1Michel S, Jomard A, Demarchez M. Pharmacology of adapalene [ J ]. Br J Dermatol,1998,139(52) :3 -7.
2Cunliffe WJ. A new topical retinoid-why a new topical acne therapy [ J ] ? Br J Dermatol,1998,139(52): 1 -2.
3Braham S, Serge M ,Sophia A. Pharmacology and chemistry of adapalene [ J ]. J Am Acad Dermatol, 1997,36:96 - 103.
4John E, Wolf Jr. Potential Anti-inflammatory effects of topical retinoids and retinoid analogues [ J ]. Advances in Therapy, 2002, 19(3) :109 -118.
5Diane Thiboutot, Michael H, Michael T, et al. Randomized controlled trial of the tolerability, safety and efficacy of Adapalene Gel 0.1% and tretinoin microsphere gel 0. 1%for the treatment of acne vulgaris [ J]. Cutis,2001,68(4): 10 - 19.
6Marcus FB, Richard AH, Sheetal P, et al.Retinoids: biological function and use in the treatment of dermatological disease [ J ]. Exp Opin Invest Drugs, 1995,4 ( 7 ) :593 - 612.
7Burge SM. Topical isotretinoin in Darier' s Disease[ J ]. Br J Dermatol, 1995,133: 924- 928.
8Cianchini G, Colonna L, Camaioni D. Acral Darier' s Disease Successfully Treated with Adapalene[ J ]. Acta Derm Venereol, 2001,81:57 -58.
9Michael TG,Dearborn MI. Using Adapalene to treat photodamage [ J ]. Skin & Aging,2000.4 - 7.
10Sylvie E. How Adapalene can treat actinic keratoses[ J]. Skin & Aging,2000.12 - 15.
5Doshi A, Zaheer A, Stiller M J. A comparison of current acne grading systems andproposal of a novel system. Int J Dermatol,1997, 36,416.
6Jansen T. Perioral dermatitis successfully treated with topical adapalene. European Academy of Dermatology and Venereology,2002,10(3 ) : 175.
7Diane thiboutot, Michael H, Miehael T, et al. Randomized controlled trial of the tolerability,safety and efficacy of Adapalene Gel 0.1% and treatment of acne vulgaris. Cutis ,2001,68 (4) : 10.
8Gollnick H, Current perspectives on the treatment of acne vulgaris and implications for future directions. JEADV,2001,15 (3) : 1.
9Czernielewske J, Michel S, Bouclier M, et al. Adapalene biochemistry and the evolution of a new topical retionoid for treatment of ache. JEADV,2001,15(3) :5.
10Galvin S A, Gilbert R, Baker M, et al. Comparative tolerance of ada-palene 0.1% gel and six different tretinoin formulations for future directions. JEADV,2001, 15 (3) : 1.
